Pricing Log in Create free account

Avenue Therapeutics, Inc. (ATXI) vs Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI)

Avenue Therapeutics, Inc. and Scinai Immunotherapeutics Ltd. Sponsored ADR are both Biotechnology companies. Avenue Therapeutics, Inc. and Scinai Immunotherapeutics Ltd. Sponsored ADR are of similar size ($680.0K and $640.0K). Avenue Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Scinai Immunotherapeutics Ltd. Sponsored ADR trades at 0.0×. Across the 10 metrics below, Scinai Immunotherapeutics Ltd. Sponsored ADR leads on 6 and Avenue Therapeutics, Inc. on 4.

Valuation

Metric ATXI SCNI Biotechnology median
P/E n/m 0.01 8.50
P/S n/m n/m 9.71
P/B 2.49 0.05 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.05 0.28 0.64
EV/Sales n/m n/m 9.21
Earnings yield (197.67%) 11,368.55% (33.15%)
Free cash flow yield (97.68%) (2,331.48%) (25.50%)

Profitability

Metric ATXI SCNI Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.30%) 0.00% (56.36%)
Return on assets (90.50%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATXI SCNI Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 89.70% (159.83%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATXI SCNI Biotechnology median
Debt to equity 0.00 0.02 0.00
Current ratio 1.40 1.56 4.72
Net debt to EBITDA 0.93 0.25 0.96

Dividend

Metric ATXI SCNI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ATXI SCNI Biotechnology median
Market cap 680.00k 640.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack